Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System

PURPOSE: Standard-of-care therapies for metastatic renal cell carcinoma (mRCC) have greatly evolved. However, the availability of emerging options in global health care systems can vary. We sought to describe the integration and usage of systemic therapies for mRCC in Canada since 2011. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardenas, Luisa M., Ghosh, Sunita, Finelli, Antonio, Wood, Lori, Kollmannsberger, Christian, Basappa, Naveen, Graham, Jeffrey, Heng, Daniel, Bjarnason, Georg, Soulières, Denis, Bossé, Dominick, Castonguay, Vincent, Saleh, Ramy, Tanguay, Simon, Bhindi, Bimal, Breau, Rodney H., Pouliot, Frederic, Lalani, Aly-Khan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681568/
https://www.ncbi.nlm.nih.gov/pubmed/37992270
http://dx.doi.org/10.1200/GO.23.00271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681568/
https://www.ncbi.nlm.nih.gov/pubmed/37992270
http://dx.doi.org/10.1200/GO.23.00271

Ejemplares similares